European company

Market Info

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info

  • Market Cap€49.570m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCH0308403085

Company Profile

GeNeuro SA is a clinical stage pharmaceutical company. It is developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis and other diseases associated with human endogenous retroviruses.